Literature DB >> 30859549

Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas.

Fredrik Ellin1, Matthew J Maurer2, Line Srour3,4, Umar Farooq5, Mats Jerkeman1, Joseph M Connors6, Karin E Smedby7, N Nora Bennani8, Stephen M Ansell8, Graham W Slack9, James R Cerhan2, Thomas Relander1, Andrew L Feldman10, Kerry J Savage6.   

Abstract

Entities:  

Keywords:  zzm321990IPIzzm321990; zzm321990PITzzm321990; NCCN-IPI; peripheral T-cell lymphoma; prognostic factors

Mesh：

Year:  2019        PMID： 30859549      PMCID： PMC7046310          DOI： 10.1111/bjh.15859

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

1.  Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project.

Authors:  Dennis D Weisenburger; Kerry J Savage; Nancy Lee Harris; Randy D Gascoyne; Elaine S Jaffe; Kenneth A MacLennan; Thomas Rüdiger; Stefano Pileri; Shigeo Nakamura; Bharat Nathwani; Elias Campo; Francoise Berger; Bertrand Coiffier; Won-Seog Kim; Harald Holte; Massimo Federico; Wing Y Au; Kensei Tobinai; James O Armitage; Julie M Vose
Journal:  Blood       Date:  2011-01-26       Impact factor: 22.113

2.  Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study.

Authors:  Andrea Gallamini; Caterina Stelitano; Roberta Calvi; Monica Bellei; Daniele Mattei; Umberto Vitolo; Fortunato Morabito; Maurizio Martelli; Ercole Brusamolino; Emilio Iannitto; Francesco Zaja; Sergio Cortelazzo; Luigi Rigacci; Liliana Devizzi; Giuseppe Todeschini; Gino Santini; Maura Brugiatelli; Massimo Federico
Journal:  Blood       Date:  2003-11-26       Impact factor: 22.113

3.  Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma.

Authors:  S M Ansell; T M Habermann; P J Kurtin; T E Witzig; M G Chen; C Y Li; D J Inwards; J P Colgan
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

4.  Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

Authors:  Nathalie Mourad; Nicolas Mounier; Josette Brière; Emmanuel Raffoux; Alain Delmer; Alfred Feller; Chris J L M Meijer; Jean-François Emile; Réda Bouabdallah; André Bosly; Jacques Diebold; Corinne Haioun; Bertrand Coiffier; Christian Gisselbrecht; Philippe Gaulard
Journal:  Blood       Date:  2008-02-21       Impact factor: 22.113

5.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Authors:  Julie Vose; James Armitage; Dennis Weisenburger
Journal:  J Clin Oncol       Date:  2008-07-14       Impact factor: 44.544

6.  Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.

Authors:  Fredrik Ellin; Jenny Landström; Mats Jerkeman; Thomas Relander
Journal:  Blood       Date:  2014-07-08       Impact factor: 22.113

7.  An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.

Authors:  Zheng Zhou; Laurie H Sehn; Alfred W Rademaker; Leo I Gordon; Ann S Lacasce; Allison Crosby-Thompson; Ann Vanderplas; Andrew D Zelenetz; Gregory A Abel; Maria A Rodriguez; Auayporn Nademanee; Mark S Kaminski; Myron S Czuczman; Michael Millenson; Joyce Niland; Randy D Gascoyne; Joseph M Connors; Jonathan W Friedberg; Jane N Winter
Journal:  Blood       Date:  2013-11-21       Impact factor: 22.113

8.  Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.

Authors:  Massimo Federico; Thomas Rudiger; Monica Bellei; Bharat N Nathwani; Stefano Luminari; Bertrand Coiffier; Nancy L Harris; Elaine S Jaffe; Stefano A Pileri; Kerry J Savage; Dennis D Weisenburger; James O Armitage; Nicholas Mounier; Julie M Vose
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544
  8 in total
  5 in total

1.  Association of ST-T changes with all-cause mortality among patients with peripheral T-cell lymphomas.

Authors:  Hanzhi Du; Lihong Yang; Bin Yan; Juan Zhao; Mengchang Wang
Journal:  Open Med (Wars)       Date:  2022-07-12

2.  High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma.

Authors:  Cunte Chen; Shaohua Chen; Gengxin Luo; Liang Wang; Chengwu Zeng; Grzegorz K Przybylski; Yangqiu Li
Journal:  Biomark Res       Date:  2022-07-12

3.  Low Expression of CD5 and CD6 Is Associated with Poor Overall Survival for Patients with T-Cell Malignancies.

Authors:  Songnan Sui; Zhiyan Li; Jiaxiong Tan; Liang Wang; Gengxin Luo; Chengwu Zeng; Oscar Junhong Luo; Cunte Chen; Yangqiu Li
Journal:  J Oncol       Date:  2022-08-09       Impact factor: 4.501

Review 4.  How to Sequence Therapies in Peripheral T Cell Lymphoma.

Authors:  Kitsada Wudhikarn; N Nora Bennani
Journal:  Curr Treat Options Oncol       Date:  2021-07-02

5.  Impact of comorbidity in older patients with peripheral T-cell lymphoma: an international retrospective analysis of 891 patients.

Authors:  Monica Mead; Henrik Cederleuf; Maja Björklund; Xiaoyan Wang; Thomas Relander; Mats Jerkeman; Daria Gaut; Sarah Larson; Fredrik Ellin
Journal:  Blood Adv       Date:  2022-04-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.